| Literature DB >> 28140557 |
Alexis M Ziemba, Manoj K Gottipati1, Filbert Totsingan, Cheryl M Hanes2, Richard A Gross, Michelle R Lennartz2, Ryan J Gilbert.
Abstract
Peritoneal macrophages (PMACs) and spinal cord astrocytes were exposed to varying concentrations of soluble sophorolipid butyl ester diacetate (SLBEDA) in vitro. Macrophages and astrocytes demonstrated no decrease in viability in response to SLBEDA. Studying pro- and anti-inflammatory genes, PMACs did not show a shift toward a pro-inflammatory phenotype. However, at higher concentrations (3 and 30 μM), astrocytes showed an increase in their expression of glial acidic fibrillary protein. This novel category of compounds poses low risk to PMAC and astrocyte viability; however, the effect on PMAC polarization and astrocyte reactivity requires more elucidation.Entities:
Keywords: Macrophage; astrocyte; sophorolipid; spinal cord injury
Mesh:
Substances:
Year: 2017 PMID: 28140557 PMCID: PMC5563161 DOI: 10.1021/acschemneuro.6b00451
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418